Scarica l'app Stockscreener
5.60
6.35%
-0.38
Dopo l'orario di chiusura:
5.62
0.02
+0.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS - Yahoo Finance
Novavax’s Covid vaccine delayed in FDA review - The Business Journals
Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Benzinga
FDA delays full approval of Novavax COVID-19 vaccine even though it was on track for clearance - KHBS
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED) - Benzinga
Novavax (NVAX) Stock Climbs Amid FDA Approval Delay for COVID-19 Vaccine - GuruFocus
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval - Bizcommunity
US Drug Regulator Delays Novavax Covid Vaccine Approval - Barron's
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why - Nasdaq
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance - KTVZ
US FDA misses deadline for decision on Novavax's COVID-19 vaccine - Reuters
Novavax Can Confirm That April 1, Was U.S FDA'S PDUFA Date For BLA Seeking Approval Of Our Covid-19 Vaccine - MarketScreener
Novavax set to snap six days of losses as shares trade in green - MSN
Novavax awaits FDA decision on COVID-19 vaccine BLA - Investing.com India
Novavax (NVAX) COVID-19 Vaccine Approval Delayed by FDA - GuruFocus
Novavax awaits FDA decision on COVID-19 vaccine BLA By Investing.com - Investing.com UK
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine - Benzinga
Novavax (NasdaqGS:NVAX) Sees 21% Weekly Drop As Leadership Changes Shake Market - Yahoo Finance
Exclusive | FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official - WSJ
Novavax bid for full approval of COVID vaccine stymied by FDA - Seeking Alpha
FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports - TradingView
FDA Misses Deadline For Covid-19 Vaccine Decision, Novavax's Application Needed More Data- WSJ - MarketScreener
The Market Doesn't Like What It Sees From Novavax, Inc.'s (NASDAQ:NVAX) Revenues Yet As Shares Tumble 28% - simplywall.st
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' - Fortune
Moderna, Novavax Drop After FDA’s Top Vaccine Official Exits - Bloomberg.com
Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
FDA official’s ouster sends shares of vaccine makers sliding - Yahoo Finance
Novavax seeks authorization of updated COVID shot in Europe - MSN
Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia
Where are the Opportunities in (NVAX) - Stock Traders Daily
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
Ebola Vaccine Market Generated Opportunities, Future Scope - openPR
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):